Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (461-470 of 4,677) with videos related to

Pageof 468
Sort By:
Cancer Discovery|November 5, 2014
Collateral genome instability by DNA damage in mitosisNannette Jelluma, Geert J P L Kops
Cancer Discovery|November 5, 2014
T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer
Cancer Discovery|November 5, 2014
GNAS a tumor suppressor in medulloblastoma
Cancer Discovery|November 13, 2014
NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growthThaned Kangsamaksin, Aino Murtomaki, Natalie M Kofler, et al.
Cancer Discovery|October 15, 2013
Hypoxia signaling--license to metastasizeSakari Vanharanta, Joan Massagué
Cancer Discovery|November 17, 2019
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell CancerLawrence Fong, Andrew Hotson, John D Powderly, et al.
Cancer Discovery|December 8, 2019
TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> LossLianxin Hu, Haibiao Xie, Xijuan Liu, et al.
Cancer Discovery|November 6, 2019
MCLA-128 Fights <i>NRG1</i> Fusion-Positive Cancers
Cancer Discovery|November 7, 2019
NSCLC Evolution Studies Refine Biomarkers
Cancer Discovery|December 11, 2019
Bempegaldesleukin Ups Melanoma Responses
Pageof 468

Showing results (461-470 of 4,677) with videos related to

Sort By:
Pageof 468
Cancer Discovery|November 5, 2014
Collateral genome instability by DNA damage in mitosisNannette Jelluma, Geert J P L Kops
Cancer Discovery|November 5, 2014
T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer
Cancer Discovery|November 5, 2014
GNAS a tumor suppressor in medulloblastoma
Cancer Discovery|November 13, 2014
NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growthThaned Kangsamaksin, Aino Murtomaki, Natalie M Kofler, et al.
Cancer Discovery|October 15, 2013
Hypoxia signaling--license to metastasizeSakari Vanharanta, Joan Massagué
Cancer Discovery|November 17, 2019
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell CancerLawrence Fong, Andrew Hotson, John D Powderly, et al.
Cancer Discovery|December 8, 2019
TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> LossLianxin Hu, Haibiao Xie, Xijuan Liu, et al.
Cancer Discovery|November 6, 2019
MCLA-128 Fights <i>NRG1</i> Fusion-Positive Cancers
Cancer Discovery|November 7, 2019
NSCLC Evolution Studies Refine Biomarkers
Cancer Discovery|December 11, 2019
Bempegaldesleukin Ups Melanoma Responses
Pageof 468